IR-Med Inc.
IRME · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $32,949 | $79,815 | $33,789 | $138,844 |
| - Cash | $129 | $767 | $3,002 | $2,815 |
| + Debt | $157 | $200 | $276 | $177 |
| Enterprise Value | $32,977 | $79,248 | $31,063 | $136,206 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$21 | -$17 | -$10 | -$5 |
| % Margin | – | – | – | – |
| EBITDA | -$1,875 | -$4,892 | -$4,752 | -$3,670 |
| % Margin | – | – | – | – |
| Net Income | -$1,899 | -$4,909 | -$9,462 | -$3,721 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.027 | -0.071 | -0.14 | -0.059 |
| % Growth | 62% | 49.5% | -137.3% | – |
| Operating Cash Flow | -$1,386 | -$3,232 | -$3,375 | -$2,482 |
| Capital Expenditures | $0 | -$2 | -$50 | -$31 |
| Free Cash Flow | -$1,386 | -$3,234 | -$3,425 | -$2,513 |